Page last updated: 2024-08-24

triazoles and Hepatitis B

triazoles has been researched along with Hepatitis B in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, J; Liu, B; Liu, Y; Lu, J; Ma, H; Peng, Y; Qiao, Y; Song, C; Wang, J; Wu, J; Yu, W1
Siegel, MO1
Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G1
Asmuth, DM; Bansal, M; Fätkenheuer, G; Heera, J; Pialoux, G; Pineda, JA; Plonski, F; Rockstroh, JK; Small, CB; Wang, R; Zhang-Roper, R1
Chawla, PS; Kochar, MS1
Bellos, N; Cooper, DA; Dunne, MW; Fätkenheuer, G; Felstead, S; Hirschel, B; Hoepelman, AI; Konourina, I; Lampiris, H; Lazzarin, A; Mayer, H; Nelson, M; Raffi, F; Ridgway, C; Saag, M; Sullivan, JF; Tawadrous, M; Tebas, P; Trottier, B; van der Ryst, E; Westby, M1
Dufty, NE; Else, LJ; Gilleran, G; Hawkins, D; Taylor, S1

Reviews

1 review(s) available for triazoles and Hepatitis B

ArticleYear
What's new in clinical pharmacology and therapeutics.
    WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2

    Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines

2008

Trials

1 trial(s) available for triazoles and Hepatitis B

ArticleYear
Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial.
    Antiviral therapy, 2017, Volume: 22, Issue:3

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Coinfection; Cyclohexanes; Female; Hepatitis B; Hepatitis C; HIV Fusion Inhibitors; HIV Infections; Humans; Liver; Liver Function Tests; Male; Maraviroc; Middle Aged; Treatment Outcome; Triazoles; Viral Load

2017

Other Studies

5 other study(ies) available for triazoles and Hepatitis B

ArticleYear
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Animals; Antiviral Agents; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Ducks; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B Virus, Duck; Humans; Models, Molecular; Molecular Structure; Monosaccharides; Nucleosides; Structure-Activity Relationship; Triazoles; Virus Replication

2018
Reactivation of hepatitis B virus infection associated with maraviroc use in an HIV-infected patient.
    AIDS (London, England), 2014, Apr-24, Volume: 28, Issue:7

    Topics: Aged; Anti-HIV Agents; Cyclohexanes; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Maraviroc; Triazoles; Virus Activation

2014
Invasive cardiac aspergillosis after orthotopic liver transplantation.
    Zeitschrift fur Gastroenterologie, 2014, Volume: 52, Issue:8

    Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles

2014
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
    The New England journal of medicine, 2008, Oct-02, Volume: 359, Issue:14

    Topics: Adult; Aged; Anti-Retroviral Agents; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Double-Blind Method; Drug Therapy, Combination; Enfuvirtide; Ethnicity; Female; Genotype; Hepatitis B; Hepatitis C; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Odds Ratio; Peptide Fragments; Receptors, CCR5; RNA, Viral; Transaminases; Treatment Outcome; Triazoles; Viral Load

2008
Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4

    Topics: Anti-HIV Agents; Carcinoma, Hepatocellular; Cyclohexanes; Drug Interactions; Hepatitis B; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Maraviroc; Middle Aged; Plasma; Tacrolimus; Treatment Outcome; Triazoles

2013